Celltrion-Hospira's Inflectra wins EU nod

The European Commission approved Hospira and Celltrion's Inflectra, a biosimilar version of rheumatoid arthritis drug Remicade from Johnson & Johnson and Merck & Co. The approval makes Inflectra the first biosimilar monoclonal antibody drug cleared in the European Union.

View Full Article in:

Wall Street Journal (tiered subscription model), The · American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC